Cell surface markers of regulatory T cells are not associated with increased forkhead box p3 expression in blood CD4+ T cells from HIV-infected patients responding to antiretroviral therapy

Immunology and Cell Biology

Volumn 84, Issue 6, 2006, Pages 530-536

  Lim, Andrew Y F ^a,c   Price, Patricia ^a   Beilharz, Manfred W ^a   French, Martyn A ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c Medical Research Foundation Building   (Australia)

Author keywords

Flow cytometry; Foxp3; HIV; Regulatory T cell

Indexed keywords

CELL SURFACE MARKER; INTERLEUKIN 2 RECEPTOR ALPHA; NEUROPILIN 1; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MALE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANTI-RETROVIRAL AGENTS; ANTIGENS, CD; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; HIV INFECTIONS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; NEUROPILIN-1; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD; VIRUS REPLICATION;

EID: 33750463102     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2006.01467.x     Document Type: Article

References (37)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-64.
2. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001; 167: 1245-53.
3. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001; 193: 1285-94.
4. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 2001; 193: 1303-10.
5. Sakaguchi S, Sakaguchi N, Shimizu J et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 2001; 182: 18-32.
6. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003; 3: 199-210.
7. Curotto de Lafaille MA, Lafaille JJ. CD4(+) regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 2002; 14: 771-8.
8. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 2004; 4: 841-55.
9. Beilharz MW, Sammels LM, Paun A et al. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression. J. Immunol. 2004; 172: 4917-25.
10. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat. Immunol. 2005; 6: 353-60.
11. Fritzsching B, Oberle N, Eberhardt N et al. In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J. Immunol. 2005; 175: 32-6.
12. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat. Med. 2004; 10: 801-5.
13. O'neill EJ, Sundstedt A, Mazza G et al. Natural and induced regulatory T cells. Ann. N.Y. Acad. Sci. 2004; 1029: 180-92.
14. Takahashi T, Tagami T, Yamazaki S et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2000; 192: 303-9.
15. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002; 3: 135-42.
16. Bruder D, Probst-Kepper M, Westendorf AM et al. Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 2004; 34: 623-30.
17. Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T cells. Immunity 2004; 21: 503-13.
18. Lederman HM, Williams PL, Wu JW et al. AIDS Clinical Trials Group 889 Study Team. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ T-cell depletion. J. Infect. Dis. 2003; 188: 1794-803.
19. Burgess K, Price P, James IR et al. Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART. J. Clin. Immunol. 2006; 26: 160-7.
20. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 2004; 78: 2454-9.
21. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104: 3249-56.
22. Oswald-Richter K, Grill SM, Shariat N et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2004; 2: 955-66.
23. Tsunemi S, Iwasaki T, Imado T et al. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS 2005; 19: 879-86.
24. Apoil PA, Puissant B, Roubinet F, Abbal M, Massip P, Blancher A. FoxP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients. J. Acquir. Immune Defic. Syndr. 2005; 39: 381-5.
25. Andersson J, Boasso A, Nilsson J et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 2005; 174: 3143-7.
26. Roncador G, Brown PJ, Maestre L et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 2005; 35: 1681-91.
27. Sakaguchi S. The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J. Clin. Invest. 2003; 112: 1310-12.
28. Nielsen J, Holm TL, Claesson MH. CD4+CD25+ regulatory T cells: II. Origin, disease models and clinical aspects. APMIS 2004; 112: 642-50.
29. Douek DC, Betts MR, Hill BJ et al. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J. Immunol. 2001; 167: 6663-8.
30. Younes SA, Yassine-Diab B, Dumont AR et al. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J. Exp. Med. 2003; 198: 1909-22.
31. Kinter AL, Hennessey M, Bell A et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 2004; 200: 331-43.
32. Hunt PW, Martin JN, Sinclair E et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 2003; 187: 1534-43.
33. Almeida CA, Price P, French MA. Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 2002; 18: 1351-5.
34. Li Z, Mahesh SP, Kim BJ, Buggage RR, Nussenblatt RB. Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J. Autoimmun. 2003; 21: 83-92.
35. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 2003; 33: 215-23.
36. Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 2004; 200: 201-10.
37. Pantaleo G, Graziosi C, Butini L et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl Acad. Sci. USA 1991; 88: 9838-42.